Kiran Kumar Asarpota
Director of Finance/CFO chez ASLAN PHARMACEUTICALS LIMITED
Fortune : 14 252 $ au 31/03/2024
Profil
Mr. Kiran K.
Asarpota is a Chief Operating Officer & Head-Finance at Aslan Pharmaceuticals Ltd.
and a Chief Operating Officer at ASLAN Pharmaceuticals Pte Ltd.
He is on the Board of Directors at Aslan Pharmaceuticals (Shanghai) Co. Ltd.
and Aslan Pharmaceuticals Taiwan Ltd.
Mr. Asarpota was previously employed as a Group Finance Director by Global Brands Group Holding Ltd.
and a Group Finance Director by Global Brands Group Pte Ltd.
He received his undergraduate degree from Oxford Brookes University and an MBA from London South Bank University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/02/2023 | 115 871 ( 0,03% ) | 14 252 $ | 31/03/2024 |
Postes actifs de Kiran Kumar Asarpota
| Sociétés | Poste | Début |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Director of Finance/CFO | 01/11/2010 |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Chief Operating Officer | - |
Aslan Pharmaceuticals Taiwan Ltd.
 Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The private company is based in Taipei, Taiwan and was founded in 2014. | Director/Board Member | - |
| Aslan Pharmaceuticals (Shanghai) Co. Ltd. | Director/Board Member | - |
Anciens postes connus de Kiran Kumar Asarpota
| Sociétés | Poste | Fin |
|---|---|---|
Global Brands Group Pte Ltd.
 Global Brands Group Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Global Brands Group Pte Ltd. provides product licensing, brand management, and retail development services. The firm offers services for sports, entertainment, and lifestyle brands. Its brand partners include PGA TOUR, FIBA, FIFA, Playground Productions, Chorion, Evisu, and IPC Media. The firm also operates in Asia, Australasia, Europe, Middle East, North & South America, and South Africa. The company was founded in September 2003 by David St. George and Jonathan Sieff and is headquartered in Singapore City, Singapore. | Director of Finance/CFO | 01/01/2010 |
| GLOBAL BRANDS GROUP HOLDING LIMITED | Director of Finance/CFO | 01/01/2010 |
Formation de Kiran Kumar Asarpota
| Oxford Brookes University | Undergraduate Degree |
| London South Bank University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GLOBAL BRANDS GROUP HOLDING LIMITED | Consumer Non-Durables |
| ASLAN PHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Global Brands Group Pte Ltd.
Global Brands Group Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Global Brands Group Pte Ltd. provides product licensing, brand management, and retail development services. The firm offers services for sports, entertainment, and lifestyle brands. Its brand partners include PGA TOUR, FIBA, FIFA, Playground Productions, Chorion, Evisu, and IPC Media. The firm also operates in Asia, Australasia, Europe, Middle East, North & South America, and South Africa. The company was founded in September 2003 by David St. George and Jonathan Sieff and is headquartered in Singapore City, Singapore. | Commercial Services |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Aslan Pharmaceuticals Taiwan Ltd.
Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The private company is based in Taipei, Taiwan and was founded in 2014. | Health Technology |
| Aslan Pharmaceuticals (Shanghai) Co. Ltd. |
